Caplin Point Laboratories (CAPLIPOINT.NS) Stock Price
Caplin Point Laboratories Price
Revenue has compounded at 24.4% per year over the past 18 years to 19.37 B INR. Earnings per share have grown at 37.9% per year over the last 18 years. Caplin Point Laboratories's net margin stands at 27.7%, up from 22.8% several years earlier. Caplin Point Laboratories currently offers a dividend yield of about 0.26%. The payout ratio is around 9% of earnings. The dividend has grown at 20.1% per year over the past 11 years. Analysts set a median price target of 2,198.10 INR, implying 3.0% below the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Caplin Point Laboratories stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Caplin Point Laboratories business model & stock analysis
Frequently asked questions about Caplin Point Laboratories
Analysts currently set an average price target of 2,198.10 INR for the Caplin Point Laboratories stock (median: 2,198.10 INR), implying -3.0 % versus the latest price. The consensus is based on 7 analyst ratings.
8 analysts currently rate the Caplin Point Laboratories stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Caplin Point Laboratories to generate revenue of 21.28 B INR and earnings per share of 80.91 INR.
Converted at the current exchange rate, the Caplin Point Laboratories share trades at 21.27 EUR (2,265.20 INR).
The Caplin Point Laboratories share (CAPLIPOINT.NS) is listed on 2 stock exchanges, including: NSE (Indien) (CAPLIPOINT.NS).
The expected revenue of Caplin Point Laboratories is 21.28 B INR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Caplin Point Laboratories is 6.16 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Caplin Point Laboratories is currently 28.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Caplin Point Laboratories stock.
The price-to-sales ratio (P/S) of Caplin Point Laboratories is currently 8.11. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Caplin Point Laboratories stock.
The Eulerpool Quality Score for Caplin Point Laboratories is 8/10.
The ISIN of Caplin Point Laboratories is INE475E01026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Caplin Point Laboratories is CAPLIPOINT.NS. The ticker symbol is used to trade Caplin Point Laboratories shares on the stock exchange.
Caplin Point Laboratories stock
Caplin Point Laboratories Peer Group
Caplin Point Laboratories Ticker
Caplin Point Laboratories FIGI
All fundamentals and in-depth analysis of Caplin Point Laboratories
Our stock analysis for Caplin Point Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Caplin Point Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.